Mouse BMDM differentiation and culture

NJ Nicholas Jones
JB Julianna Blagih
FZ Fabio Zani
AR April Rees
DH David G. Hill
BJ Benjamin J. Jenkins
CB Caroline J. Bull
DM Diana Moreira
AB Azari I. M. Bantan
JC James G. Cronin
DA Daniele Avancini
GJ Gareth W. Jones
DF David K. Finlay
KV Karen H. Vousden
EV Emma E. Vincent
CT Catherine A. Thornton
request Request a Protocol
ask Ask a question
Favorite

Hind legs were collected from C57/B6J mice (aged 6–15 weeks) and cleaned using a scalpel, followed by flushing of the bone marrow with a 1 mL syringe, phosphate-buffered saline (PBS) and 25 G needle. Red blood cells were lysed using ACK lysis buffer following the manufacturer’s instructions (10× red blood cell lysis buffer, 420301; BioLegend). Bone marrow cells were cultured on non-tissue culture-treated 10-cm Petri dishes in complete Iscove’s modified Dulbecco’s media (IMDM), 10% FBS, 50 µM β-mercaptoethanol and supplemented with 25 ng/mL of macrophage colony-stimulating factor (315-02; Peprotech). BMDMs were supplemented with macrophage colony-stimulating factor every 3 days until day 7 of differentiation. BMDMs were activated with 1 ng/mL of LPS purchased from Sigma (E. coli O111:B4 LPS25) for either 5 or 18 h according to experiment type. Further experiments were performed with the glutaminase inhibitor CB-839 (Merck, AMBH2D6FB23B) (1 µM per well) or rapamycin (R8781; Sigma) (50 nM per well) with their respective vehicle controls.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A